about
OmniAb Inc licenses discovery research technology to pharmaceutical and biotech companies and academic institutions to enable the discovery of next-generation therapeutics. Its technology platform creates and screens diverse antibody repertoires and ...
Read More
2.18
-0.01
(-0.46%)
910.1K
XNAS Volume
High vol.+gain this week
XNAS 15 May, 2026 4:00 PM (EDT)
Not Eligible
Expensive Valuation
Technically Neutral
OmniAb Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..